Company / Gross Profit per Share
MAXCYTE, INC. Gross Profit per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.25
FY2025
5-year range
$0.25 / $0.39
FY2021-FY2025
Trend
-27.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has declined for 4 consecutive years, from $0.39 in FY2021 to $0.25 in FY2025.
Based on SEC 10-K filings.
0.25 in FY2025 with a 3-year CAGR of -13.1%.
Declined from $0.38 to $0.25 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -13.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- MAXCYTE, INC.'s gross profit per share has declined for 4 consecutive years.
- In FY2025, gross profit per share decreased 27.9% year-over-year.
- Peak gross profit per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.25 | -27.9% |
| FY2024 | $0.35 | -8.1% |
| FY2023 | $0.38 | -1.2% |
| FY2022 | $0.39 | -1.0% |
| FY2021 | $0.39 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026